SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-17-012446
Filing Date
2017-11-21
Accepted
2017-11-21 16:30:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO SCHEDULE 13D sc13d1117a5canfite_wize.htm SC 13D/A 47865
  Complete submission text file 0001213900-17-012446.txt   49633
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Subject) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82946 | Film No.: 171217221
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filed by) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations